Point-of-care Molecular Diagnostics Market : Global Industry Analysis 2016 - 2025 and Opportunity Assessment 2026 - 2036

Future Market Insights

Point-of-care Molecular Diagnostics Market

Key Insight

Point-of-care molecular diagnostics represent 52.7% of product type sales in 2026. The point-of-care molecular diagnostics market is estimated at USD 5.8 billion in 2026, is projected to reach USD 15.1 billion by 2036 and is forecast to post a 10.0% CAGR between 2026 and 2036.

June 16, 2026

Anurag Sharma

317 Pages

Cite this Report

Point-of-care Molecular Diagnostics Market

https://www.futuremarketinsights.com/reports/point-of-care-molecular-diagnostics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Abbott Laboratories
Biomeme
Cepheid (Danaher Corporation)
Detect Inc
Mammoth Biosciences
QuidelOrtho Corporation
Hoffmann-La Roche
Sherlock Biosciences
Visby Medical

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Point-of-care Molecular Diagnostics Market

Key Players

Similar Industry Reports